(19)
(11) EP 3 294 267 A1

(12)

(43) Date of publication:
21.03.2018 Bulletin 2018/12

(21) Application number: 16733687.4

(22) Date of filing: 13.05.2016
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 36/47(2006.01)
A61P 1/02(2006.01)
A61P 17/10(2006.01)
A61L 15/40(2006.01)
A61K 36/61(2006.01)
A61P 17/06(2006.01)
A61P 17/04(2006.01)
(86) International application number:
PCT/IB2016/052770
(87) International publication number:
WO 2016/181355 (17.11.2016 Gazette 2016/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 14.05.2015 IT UB20150388

(71) Applicant: Logi, Roberto
50124 Firenze (IT)

(72) Inventor:
  • Logi, Roberto
    50124 Firenze (IT)

(74) Representative: Brazzini, Silvia et al
Società Italiana Brevetti S.p.A. Corso dei Tintori, 25
50122 Firenze
50122 Firenze (IT)

   


(54) COMPOSITIONS FOR TREATING AND/OR PREVENTING PSORIASIS, PRICKLY HEAT, DERMATITISES, NEUROFIBROMATOSIS TYPE 1 AND OTHER PATHOLOGIES OF THE DERMIS, MUCOSAE, AND ORAL CAVITY